ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Financial Flexibility Index
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Financial Flexibility Index of 0.19x as of September 2025. Free cash flow of CN¥312.72 Million (operating CF CN¥288.83 Million minus capex CN¥23.89 Million) represents 0% of total liabilities (CN¥1.66 Billion). Check strategic asset allocation of ZhuZhou QianJin Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ZhuZhou QianJin Pharmaceutical Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. See working capital position of ZhuZhou QianJin Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for ZhuZhou QianJin Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600479 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | CN¥604.41 Million | CN¥480.24 Million | CN¥1.61 Billion | ▲ +19.0% |
| 2024 | 0.31x | CN¥446.09 Million | CN¥398.77 Million | CN¥1.42 Billion | ▲ +6.6% |
| 2023 | 0.30x | CN¥487.10 Million | CN¥443.12 Million | CN¥1.65 Billion | ▼ -30.1% |
| 2022 | 0.42x | CN¥767.91 Million | CN¥733.47 Million | CN¥1.82 Billion | ▲ +3.1% |
| 2021 | 0.41x | CN¥557.45 Million | CN¥485.57 Million | CN¥1.36 Billion | ▼ -6.0% |
| 2020 | 0.44x | CN¥639.61 Million | CN¥542.37 Million | CN¥1.47 Billion | ▲ +163.0% |
| 2019 | 0.17x | CN¥196.11 Million | CN¥155.49 Million | CN¥1.18 Billion | ▼ -59.8% |
| 2018 | 0.41x | CN¥429.86 Million | CN¥383.47 Million | CN¥1.04 Billion | ▲ +26.5% |
| 2017 | 0.33x | CN¥340.77 Million | CN¥283.47 Million | CN¥1.05 Billion | ▲ +38.9% |
| 2016 | 0.23x | CN¥222.38 Million | CN¥140.88 Million | CN¥948.21 Million | ▲ +20.3% |
| 2015 | 0.20x | CN¥151.96 Million | CN¥67.48 Million | CN¥779.17 Million | ▼ -34.0% |
| 2014 | 0.30x | CN¥249.32 Million | CN¥183.34 Million | CN¥843.20 Million | ▼ -8.9% |
| 2013 | 0.32x | CN¥221.89 Million | CN¥137.63 Million | CN¥683.92 Million | ▼ -58.5% |
| 2012 | 0.78x | CN¥454.08 Million | CN¥197.82 Million | CN¥581.18 Million | ▲ +160.4% |
| 2011 | 0.30x | CN¥86.45 Million | CN¥22.58 Million | CN¥288.10 Million | ▼ -42.0% |
| 2010 | 0.52x | CN¥97.57 Million | CN¥39.13 Million | CN¥188.65 Million | ▼ -17.4% |
| 2009 | 0.63x | CN¥196.85 Million | CN¥73.54 Million | CN¥314.48 Million | ▼ -13.2% |
| 2008 | 0.72x | CN¥132.51 Million | CN¥37.20 Million | CN¥183.66 Million | ▲ +34.2% |
| 2007 | 0.54x | CN¥101.80 Million | CN¥79.26 Million | CN¥189.30 Million | ▼ -35.7% |
| 2006 | 0.84x | CN¥141.51 Million | CN¥120.12 Million | CN¥169.13 Million | ▲ +82.5% |
| 2005 | 0.46x | CN¥93.24 Million | CN¥76.50 Million | CN¥203.38 Million | ▼ -9.2% |
| 2004 | 0.51x | CN¥74.95 Million | CN¥18.45 Million | CN¥148.38 Million | ▲ +11.8% |
| 2003 | 0.45x | CN¥85.01 Million | CN¥50.96 Million | CN¥188.23 Million | ▲ +20.5% |
| 2002 | 0.37x | CN¥65.31 Million | CN¥6.07 Million | CN¥174.31 Million | — |